Jan 11 (Reuters) - EUROCINE VACCINES AB:
* EUROCINE VACCINES OBTAINS AUTHORIZATION TO CONDUCT THE NEXT STUDY WITH IMMUNOSE™ FLU
* GOT AUTHORIZATION TO CONDUCT A PHASE I/II CLINICAL STUDY ON QUADRIVALENT INFLUENZA VACCINE CANDIDATE IMMUNOSE™ FLU
* RESULTS CAN BE EXPECTED SECOND HALF OF 2018. * AUTHORIZATIONS TO CONDUCT STUDY RECEIVED FROM ‍SWEDISH MEDICAL PRODUCTS AGENCY AND ETHICS COMMITTEE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Our Standards: The Thomson Reuters Trust Principles.